Ronald E. Steele

3.7k total citations
43 papers, 2.9k citations indexed

About

Ronald E. Steele is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Ronald E. Steele has authored 43 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 16 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Genetics. Recurrent topics in Ronald E. Steele's work include Kidney Stones and Urolithiasis Treatments (14 papers), Estrogen and related hormone effects (11 papers) and Hormonal and reproductive studies (7 papers). Ronald E. Steele is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (14 papers), Estrogen and related hormone effects (11 papers) and Hormonal and reproductive studies (7 papers). Ronald E. Steele collaborates with scholars based in United States, Switzerland and Italy. Ronald E. Steele's co-authors include James E. Lingeman, Phillip G. Mosbaugh, Daniel M. Newman, Thomas A. Coury, John R. Woods, Richard J. Kahnoski, Peter M. Knapp, John H.O. Mertz, Leslie J. Browne and Andrzej Bartke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.

In The Last Decade

Ronald E. Steele

43 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald E. Steele United States 26 1.6k 878 509 402 398 43 2.9k
M. Ziegler Germany 26 809 0.5× 182 0.2× 564 1.1× 567 1.4× 899 2.3× 181 2.5k
Yutaro Hayashi Japan 32 806 0.5× 482 0.5× 234 0.5× 383 1.0× 1.4k 3.5× 277 3.7k
Yoshiyuki Kojima Japan 31 1.0k 0.7× 402 0.5× 244 0.5× 258 0.6× 986 2.5× 279 3.6k
Pieter De Moor Belgium 41 434 0.3× 463 0.5× 1.9k 3.8× 649 1.6× 984 2.5× 171 5.2k
S Klahr United States 34 707 0.4× 520 0.6× 456 0.9× 361 0.9× 1.3k 3.2× 151 4.2k
A S Harris United States 26 402 0.3× 206 0.2× 107 0.2× 126 0.3× 731 1.8× 44 2.1k
Joseph Sack Israel 25 310 0.2× 523 0.6× 1.2k 2.3× 359 0.9× 793 2.0× 103 2.6k
Thomas Maack United States 37 1.1k 0.7× 390 0.4× 639 1.3× 178 0.4× 2.2k 5.5× 82 6.1k
Michel Baum United States 37 964 0.6× 1.1k 1.3× 404 0.8× 1.2k 2.9× 2.2k 5.4× 135 5.2k
David Sheikh‐Hamad United States 36 419 0.3× 231 0.3× 217 0.4× 206 0.5× 1.6k 3.9× 78 3.7k

Countries citing papers authored by Ronald E. Steele

Since Specialization
Citations

This map shows the geographic impact of Ronald E. Steele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald E. Steele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald E. Steele more than expected).

Fields of papers citing papers by Ronald E. Steele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald E. Steele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald E. Steele. The network helps show where Ronald E. Steele may publish in the future.

Co-authorship network of co-authors of Ronald E. Steele

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald E. Steele. A scholar is included among the top collaborators of Ronald E. Steele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald E. Steele. Ronald E. Steele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mulatero, Paolo, Grégoire Wuerzner, Michael Groessl, et al.. (2024). Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial. EClinicalMedicine. 71. 102576–102576. 25 indexed citations
2.
Pignatti, Emanuele, Daniela Schuster, Ronald E. Steele, et al.. (2023). Structural and clinical characterization of CYP11B2 inhibition by dexfadrostat phosphate. The Journal of Steroid Biochemistry and Molecular Biology. 235. 106409–106409. 7 indexed citations
3.
Schumacher, Christoph, Ronald E. Steele, & Hans R. Brunner. (2013). Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy. Journal of Hypertension. 31(10). 2085–2093. 43 indexed citations
4.
Honer, Christian, Kiyean Nam, Cynthia A. Fink, et al.. (2003). Glucocorticoid Receptor Antagonism by Cyproterone Acetate and RU486. Molecular Pharmacology. 63(5). 1012–1020. 78 indexed citations
5.
Kuo, Ramsay L., Ryan F. Paterson, Tibério M. Siqueira, et al.. (2003). Holmium laser enucleation of the prostate: morbidity in a series of 206 patients. Urology. 62(1). 59–63. 54 indexed citations
6.
Stanton, James L., et al.. (2000). Synthesis and biological activity of phenoxyphenyl oxamic acid derivatives related to l-thyronine. Bioorganic & Medicinal Chemistry Letters. 10(15). 1661–1663. 15 indexed citations
7.
Taylor, Anthony H., et al.. (1997). Beneficial Effects of a Novel Thyromimetic on Lipoprotein Metabolism. Molecular Pharmacology. 52(3). 542–547. 68 indexed citations
8.
Wasvary, Jong M., et al.. (1996). Demonstration of potent lipid-lowering activity by a thyromimetic agent devoid of cardiovascular and thermogenic effects. Atherosclerosis. 126(1). 53–63. 18 indexed citations
9.
Wasvary, Jong M., et al.. (1992). Reduction of cardiovascular and thyroxine-suppressing activities of L-T3 by liver targeting with cholic acid. Biochemical Pharmacology. 43(9). 1969–1974. 40 indexed citations
10.
Browne, Leslie J., Candido Gude, Heriberto Rodríguez Frausto, Ronald E. Steele, & A.K. Bhatnager. (1991). Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease. Journal of Medicinal Chemistry. 34(2). 725–736. 201 indexed citations
11.
Steele, Ronald E., et al.. (1991). Effect of L‐thyroxine (LT4) and D‐thyroxine (DT4) on cardiac function and high‐energy phosphate metabolism: A 31P NMR study. Magnetic Resonance in Medicine. 18(1). 237–243. 1 indexed citations
12.
Bhatnagar, A.S., et al.. (1990). Novel aromatase inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 37(3). 363–367. 28 indexed citations
13.
Oesterling, Joseph E., Paul E. Juniewicz, John D. Strandberg, et al.. (1988). Aromatase Inhibition in the Dog. II. Effect on Growth, Function, and Pathology of the Prostate. The Journal of Urology. 139(4). 832–839. 27 indexed citations
14.
Lingeman, James E., Thomas A. Coury, Daniel M. Newman, et al.. (1987). Comparison of Results and Morbidity of Percutaneous Nephrostolithotomy and Extracorporeal Shock Wave Lithotripsy. The Journal of Urology. 138(3). 485–490. 202 indexed citations
15.
Lingeman, James E., et al.. (1987). Management of Upper Ureteral Calculi with Extracorporeal Shock wave Lithotripsy. The Journal of Urology. 138(4 Part 1). 720–723. 128 indexed citations
16.
Kulb, Thomas B., James E. Lingeman, Thomas A. Coury, et al.. (1986). Extracorporeal Shock Wave Lithotripsy in Patients with a Solitary Kidney. The Journal of Urology. 136(4). 786–788. 33 indexed citations
17.
Steele, Ronald E., et al.. (1979). Toad urinary bladder epithelial cells in culture: maintenance of epithelial structure, sodium transport, and response to hormones.. Proceedings of the National Academy of Sciences. 76(8). 4151–4155. 95 indexed citations
18.
Steele, Ronald E.. (1977). Role of the Ovaries in Maturation of the Estradiol-Luteinizing Hormone Negative Feedback System of the Pubertal Rat. Endocrinology. 101(2). 587–597. 5 indexed citations
19.
Lee, Peter A., Leslie Plotnick, Ronald E. Steele, Robert G. Thompson, & Robert M. Blizzard. (1976). Integrated Concentrations of Luteinizing Hormone and Puberty. The Journal of Clinical Endocrinology & Metabolism. 43(1). 168–172. 44 indexed citations
20.
Saksena, S.K., Ronald E. Steele, & M. J. K. Harper. (1973). EFFECTS OF EXOGENOUS OESTRADIOL AND PROGESTERONE ON SERUM LEVELS OF PROSTAGLANDIN F AND LUTEINIZING HORMONE IN CHRONICALLY OVARIECTOMIZED RATS. Reproduction. 32(3). 495–499. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Ziegler Breakdown of academic impact, for papers by Yutaro Hayashi Breakdown of academic impact, for papers by Yoshiyuki Kojima Breakdown of academic impact, for papers by Pieter De Moor Breakdown of academic impact, for papers by S Klahr Breakdown of academic impact, for papers by A S Harris Breakdown of academic impact, for papers by Joseph Sack Breakdown of academic impact, for papers by Thomas Maack Breakdown of academic impact, for papers by Michel Baum Breakdown of academic impact, for papers by David Sheikh‐Hamad
Rankless by CCL
2026